prices, affordability and cost containment Dukes, M.N. Graham Graham, M.N. Joncheere, Kees de Rietveld, Ad H. text Amsterdam IOS Press © 2003 monographic eng

print

VI, 152 pages. Content: 1. Scope of the problem. -- 2. Data needed for developing and monitoring policies. -- 3. Policy options for cost containment of pharmaceuticals -- 4. Methods for monitoring and evaluating processes and outcomes. -- 5. Making use of economic evaluation. -- 6. Measures relating to use of drug subsidy lists and to regulation. -- 7. Experiences with budgets. -- 8. Experiences with reference pricing. -- 9. Experiences with patient charges. -- 10. Switching to non-prescription status. -- 11. Experiences with generics. -- 12. Experiences with pharmacy benefit management programmes in the USA. -- 13. Experiences with professional education. -- 14. Providing affordable medicines in transitional countries. -- 15. Access to medicines in low-income countries. Edited by M.N.G. Dukes [and four others] Published on behalf of the World Health Organization Regional Office for Europe by IOS Press -- Title page. 1586033344 https://www.euro.who.int/__data/assets/pdf_file/0011/96446/e79122.pdf https://www.euro.who.int/__data/assets/pdf_file/0011/96446/e79122.pdf 210123 20210123114310.0 D0001B001256